Combined Intralipid-urotherapy for Patients with Cancer: A Creative Review

Eldor, Joseph (2017) Combined Intralipid-urotherapy for Patients with Cancer: A Creative Review. Journal of Cancer and Tumor International, 5 (3). pp. 1-31. ISSN 24547360

[thumbnail of 48-Article Text-98-1-10-20220913.pdf]

Text
48-Article Text-98-1-10-20220913.pdf - Published Version
Download (505kB)

Official URL: https://doi.org/10.9734/JCTI/2017/32940

Abstract

The article relates in general to intralipid and its use in cancer therapy. Specifically, it relates to the combined intralipid-urotherapy for treating cancer, and methods of such treatment.

Cancer cells release various antigens, some of which appear in the urine. Combined oral Intralipid and auto-urotherapy is suggested as a new treatment modality for cancer patients. It will provide the intestinal lymphatic system the many tumor antigens against which antibodies may be produced. These antibodies may be transpierced through the blood stream and attack the tumor and its cells.

Intralipid can increase the response to the cancer antigens in the intestinal lymphatic system against which antibodies may be produced.

Item Type:	Article
Subjects:	European Scholar > Medical Science
Depositing User:	Managing Editor
Date Deposited:	02 Mar 2023 06:15
Last Modified:	17 Oct 2024 04:30
URI:	http://article.publish4promo.com/id/eprint/910

Actions (login required)

: View Item